Cargando…

Interaction of silver nanoparticles with Tacaribe virus

BACKGROUND: Silver nanoparticles possess many unique properties that make them attractive for use in biological applications. Recently they received attention when it was shown that 10 nm silver nanoparticles were bactericidal, which is promising in light of the growing number of antibiotic resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Speshock, Janice L, Murdock, Richard C, Braydich-Stolle, Laura K, Schrand, Amanda M, Hussain, Saber M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936366/
https://www.ncbi.nlm.nih.gov/pubmed/20718972
http://dx.doi.org/10.1186/1477-3155-8-19
_version_ 1782186478937309184
author Speshock, Janice L
Murdock, Richard C
Braydich-Stolle, Laura K
Schrand, Amanda M
Hussain, Saber M
author_facet Speshock, Janice L
Murdock, Richard C
Braydich-Stolle, Laura K
Schrand, Amanda M
Hussain, Saber M
author_sort Speshock, Janice L
collection PubMed
description BACKGROUND: Silver nanoparticles possess many unique properties that make them attractive for use in biological applications. Recently they received attention when it was shown that 10 nm silver nanoparticles were bactericidal, which is promising in light of the growing number of antibiotic resistant bacteria. An area that has been largely unexplored is the interaction of nanomaterials with viruses and the possible use of silver nanoparticles as an antiviral agent. RESULTS: This research focuses on evaluating the interaction of silver nanoparticles with a New World arenavirus, Tacaribe virus, to determine if they influence viral replication. Surprisingly exposing the virus to silver nanoparticles prior to infection actually facilitated virus uptake into the host cells, but the silver-treated virus had a significant reduction in viral RNA production and progeny virus release, which indicates that silver nanoparticles are capable of inhibiting arenavirus infection in vitro. The inhibition of viral replication must occur during early replication since although pre-infection treatment with silver nanoparticles is very effective, the post-infection addition of silver nanoparticles is only effective if administered within the first 2-4 hours of virus replication. CONCLUSIONS: Silver nanoparticles are capable of inhibiting a prototype arenavirus at non-toxic concentrations and effectively inhibit arenavirus replication when administered prior to viral infection or early after initial virus exposure. This suggests that the mode of action of viral neutralization by silver nanoparticles occurs during the early phases of viral replication.
format Text
id pubmed-2936366
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29363662010-09-10 Interaction of silver nanoparticles with Tacaribe virus Speshock, Janice L Murdock, Richard C Braydich-Stolle, Laura K Schrand, Amanda M Hussain, Saber M J Nanobiotechnology Research BACKGROUND: Silver nanoparticles possess many unique properties that make them attractive for use in biological applications. Recently they received attention when it was shown that 10 nm silver nanoparticles were bactericidal, which is promising in light of the growing number of antibiotic resistant bacteria. An area that has been largely unexplored is the interaction of nanomaterials with viruses and the possible use of silver nanoparticles as an antiviral agent. RESULTS: This research focuses on evaluating the interaction of silver nanoparticles with a New World arenavirus, Tacaribe virus, to determine if they influence viral replication. Surprisingly exposing the virus to silver nanoparticles prior to infection actually facilitated virus uptake into the host cells, but the silver-treated virus had a significant reduction in viral RNA production and progeny virus release, which indicates that silver nanoparticles are capable of inhibiting arenavirus infection in vitro. The inhibition of viral replication must occur during early replication since although pre-infection treatment with silver nanoparticles is very effective, the post-infection addition of silver nanoparticles is only effective if administered within the first 2-4 hours of virus replication. CONCLUSIONS: Silver nanoparticles are capable of inhibiting a prototype arenavirus at non-toxic concentrations and effectively inhibit arenavirus replication when administered prior to viral infection or early after initial virus exposure. This suggests that the mode of action of viral neutralization by silver nanoparticles occurs during the early phases of viral replication. BioMed Central 2010-08-18 /pmc/articles/PMC2936366/ /pubmed/20718972 http://dx.doi.org/10.1186/1477-3155-8-19 Text en Copyright ©2010 Speshock et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Speshock, Janice L
Murdock, Richard C
Braydich-Stolle, Laura K
Schrand, Amanda M
Hussain, Saber M
Interaction of silver nanoparticles with Tacaribe virus
title Interaction of silver nanoparticles with Tacaribe virus
title_full Interaction of silver nanoparticles with Tacaribe virus
title_fullStr Interaction of silver nanoparticles with Tacaribe virus
title_full_unstemmed Interaction of silver nanoparticles with Tacaribe virus
title_short Interaction of silver nanoparticles with Tacaribe virus
title_sort interaction of silver nanoparticles with tacaribe virus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936366/
https://www.ncbi.nlm.nih.gov/pubmed/20718972
http://dx.doi.org/10.1186/1477-3155-8-19
work_keys_str_mv AT speshockjanicel interactionofsilvernanoparticleswithtacaribevirus
AT murdockrichardc interactionofsilvernanoparticleswithtacaribevirus
AT braydichstollelaurak interactionofsilvernanoparticleswithtacaribevirus
AT schrandamandam interactionofsilvernanoparticleswithtacaribevirus
AT hussainsaberm interactionofsilvernanoparticleswithtacaribevirus